International Consortium of Cardiovascular Registries establishes roadmap for registry collaboration

The FDA brought together various stakeholders from across the globe on April 22 to establish the International Consortium of Cardiovascular Registries. The ground-breaking initiative, comprised of the American College of Cardiology (ACC), the Society of Thoracic Surgeons, industry and others, aims to enhance the way device registries are used across the practice of cardiology and around the world.

The effort will initially focus on registries that track the transcatheter aortic valve replacement procedure with plans to expand to additional cardiovascular registries in the future. Read more about the consortium.

Earlier in April, ACC leaders shared the College’s experience in developing registries at the China Outcomes, Research and Evidence Based Medicine (CORE) Summit in Shanghai. The summit—the only meeting in China solely dedicated to outcomes and comparative effectiveness research— brought together key players from the U.S. and Chinese governments, the medical community, industry, and academic and research organizations.